7/11/2012 – In Preventing Alzheimer’s, Mutation May Aid Drug Quest

A study of a rare gene mutation that protects people against Alzheimer’s disease provides the strongest evidence yet that excessive levels of a normal brain substance, beta amyloid, are a driving force in the disease — bolstering hopes that anti-amyloid drugs already under development might alter the disease’s course or even prevent it.

Read the full article at The New York Times.